Question 1

What are the differences in how ITCA 650 and sitagliptin work?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes clinical trial (NCT01455870). Contact the study team or your healthcare provider for specific answers.

Question 2

How might this trial affect my current diabetes treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes clinical trial (NCT01455870). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of for both treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes clinical trial (NCT01455870). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to visit the clinic if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes clinical trial (NCT01455870). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes clinical trial (NCT01455870). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any other options available if I don't qualify for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes clinical trial (NCT01455870). Contact the study team or your healthcare provider for specific answers.

What this study is about